Announcements Trials

Browse Landscape

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Melanoma 2 Uterine Cervical Neoplasms 1 Solid Tumor, Adult 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuromyelitis Optica 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 1 Myasthenia Gravis 1 Multiple Sclerosis 1 Lung Neoplasms 1 Laryngectomy; Status 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Encephalomyelitis, Acute Disseminated 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1

Interventions

Cisplatin 38 Carboplatin 28 Gemcitabine 23 Docetaxel 20 Radiotherapy 18 Etoposide 15 Paclitaxel 13 Erlotinib Hydrochloride 13 Vinorelbine 11 Drug Therapy 11 pembrolizumab 9 aumolertinib 9 apatinib 9 Pemetrexed 9 Gefitinib 9 endostar protein 7 Thoracic Surgery, Video-Assisted 7 Blood Specimen Collection 7 osimertinib 6 camrelizumab 6 anlotinib 6 Vinblastine 6 Surgical Procedures, Operative 6 sintilimab 5 Radiosurgery 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Bevacizumab 5 durvalumab 4 Mitomycin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × Data Collection × Clear all

NCT05783024 2023-05-10

ADAMpartlung

AZ Delta

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡